FrancophonIA/ELRC3.0 huggingface dataset:
English: Ioa comes in blisters containing 28 tablets (24 white tablets followed by 4 yellow tablets), which are taken in sequence using stickers to identify the days of the week for each tablet.
Estonian: Ioat turustatakse blistrites, mis sisaldavad 28 tabletti (24 valget ja 4 kollast tabletti) - tablette võetakse järjest nädalapäevadega kleepsude järgi.
English: What benefit has Ioa shown during the studies?
Estonian: Milles seisneb uuringute põhjal Ioa kasulikkus?
English: Ioa is a medicine available as 24 white ‘active' tablets that contain the active substances nomegestrol acetate (2.5 mg) and estradiol (1.5 mg), and four yellow ‘inactive' (placebo) tablets that do not
Estonian: Ioat turustatakse 24 valge toimeaineid nomegestroolatsetaati (2,5 mg) ja östradiooli (1,5 mg) sisaldava tableti ning 4 kollase platseebotabletina, mis ei sisalda toimeaineid.
English: Ioa is a combined contraceptive pill that contains two active substances, nomegestrol acetate (a progestogen) and estradiol (an oestrogen).
Estonian: Ioa on kombineeritud kontratseptiiv (kombineeritud rasestumisvastane tablett), mis sisaldab kaht toimeainet - nomegestroolatsetaati (teatud progestogeen ehk kollaskehahormoon) ja östradiooli (teatud östrogeen).
English: Ioa works by changing the body's hormonal balance to prevent ovulation, by altering the cervical mucus and by thinning the endometrium (the lining of the womb).
Estonian: Ioa muudab ovulatsiooni takistamiseks organismi hormoonitasakaalu nii, et muutub emakakaela lima koostis ja õheneb endomeetrium (emaka limaskest).
English: It should not be used in women who have a disorder affecting blood clotting (such as protein C deficiency), migraine with aura (visual or other symptoms), severe liver problems with the liver still not functioning normally, certain types of cancer, or abnormal bleeding from the genital area whose cause has not been diagnosed.
Estonian: Ioat ei tohi kasutada naised, kellel on hüübimishäireid (näiteks C-valgu vaegus), nn auraga migreen (koos visuaalsete või muude sümptomitega), rasked maksaprobleemid koos maksa talitushäiretega, teatud tüüpi vähktõbi või diagnoosimata põhjusega ebatavaline vereeritus tupest.
English: Ioa should not be used in women who are hypersensitive (allergic) to nomegestrol acetate, estradiol or any of the other ingredients.
Estonian: Ioat ei tohi kasutada naised, kes on nomegestroolatsetaadi, östradiooli või selle ravimi mis tahes muu koostisaine suhtes ülitundlikud (allergilised).
English: For the full list of restrictions, see
Estonian: Piirangute täielik loetelu on pakendi infolehel.
English: The participants were given either Ioa or another contraceptive pill containing drospirenone and ethinyl estradiol for one year (13 menstrual cycles).
Estonian: Uuringutes osalenud tarvitasid ühe aasta jooksul (13 menstruaaltsüklit) kas Ioat või drospirenooni ja etinüülöstradiooli sisaldavaid kontratseptiive.
English: For the full list of all side effects reported with Ioa,
Estonian: Ioa kohta teatatud kõrvalnähtude täielik loetelu on pakendi infolehel.
English: The Pearl Index is a standard way of measuring the effectiveness of contraceptives, which measures how many unwanted pregnancies occur in 100 women-years (corresponding to 1,300 menstrual cycles).
Estonian: Pearli indeks on rasestumisvastaste vahendite efektiivsuse standardne mõõtmisviis.
English: Ioa
Estonian: Mis on Ioa?
English: Content (concentration)
Estonian: Pakendi sisu (kontsentratsioon) Pakendi suurus
English: This was considered acceptable since Revatio and Viagra have the same qualitative composition and are made in the same way by the same manufacturer.
Estonian: Seda peeti vastuvõetavaks, sest Revatiol ja Viagral on sama kvalitatiivne koostis ning neid toodab sama meetodiga sama tootja.
English: The full EPAR for Mysildecard can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Estonian: Euroopa avaliku hindamisaruande täistekst Mysildecardi kohta on ameti veebilehel: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: 30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom dose would be 10 mg three times a day but Mysildecard can only be used when a 20 mg dose is to be given.
Estonian: 30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom maksimumannus oleks 10 mg kolm korda ööpäevas, kuid Mysildecardi tohib kasutada ainult siis, kui patsient vajab 20 mg annust.
English: In this case Mysildecard was not compared with the reference product Revatio, but with Viagra.
Estonian: Käesoleval juhul ei võrreldud Mysildecardi mitte võrdlusravimi Revatioga, vaid Viagraga.
English: What measures are being taken to ensure the safe and effective use of Mysildecard?
Estonian: Mis meetmed võetakse, et tagada Mysildecardi ohutu ja efektiivne kasutamine?
English: For lower doses, other medicines containing sildenafil should therefore be used.
Estonian: Väiksemate annuste korral tuleb seega kasutada teist sildenafiili sisaldavat ravimit.
English: In children weighing less than 20 kg the maximum recommended
Estonian: Alla 20 kg kehamassiga laste soovitatav
English: The Committee recommended that Mysildecard be approved for use in the EU.
Estonian: Komitee soovitas Mysildecardi kasutamise Euroopa Liidus heaks kiita.
English: Mysildecard is available as tablets (20 mg).
Estonian: Mysildecardi turustatakse tablettidena (20 mg).
English: Because Mysildecard is a generic medicine, its benefits and risks are taken as being the same as the reference medicine's.
Estonian: Et Mysildecard on geneeriline ravim, peetakse tema kasulikkust ja riske samadeks mis võrdlusravimil.
English: What is Mysildecard and what is it used for?
Estonian: Mis on Mysildecard ja milleks seda kasutatakse?
English: This is a summary of the European public assessment report (EPAR) for Mysildecard.
Estonian: See on ravimi Mysildecard Euroopa avaliku hindamisaruande kokkuvõte.
English: The active substance in Mysildecard, sildenafil, belongs to a group of medicines called ‘phosphodiesterase-type-5 (PDE5) inhibitors', which means that it blocks the PDE5 enzyme.
Estonian: Mysildecardi toimeaine sildenafiil kuulub fosfodiesteraas-5 (PDE5) inhibiitorite ravimirühma, st sildenafiil blokeerib ensüümi PDE5.
English: Mysildecard sildenafil
Estonian: Mysildecard sildenafiil
English: Other information about Mysildecard
Estonian: Muu teave Mysildecardi kohta
English: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Mysildecard have been included in the summary of product characteristics and the package leaflet.
Estonian: Mysildecardi ohutu ja efektiivse kasutamise soovitused ja ettevaatusmeetmed tervishoiutöötajatele ja patsientidele on lisatud ravimi omaduste kokkuvõttesse ja pakendi infolehele.
English: It is not intended to provide practical advice on how to use Mysildecard.
Estonian: Hindamisaruandes ei anta Mysildecardi kasutamise praktilisi nõuandeid.
English: The Agency's Committee for Medicinal Products for Human Use (CHMP) concluded that, in accordance with EU requirements, Mysildecard was considered to be comparable to Revatio.
Estonian: Inimravimite komitee järeldas, et vastavalt Euroopa Liidu nõuetele on tõendatud ravimi Mysildecard sarnane toime ravimiga Revatio.
English: Therefore, the CHMP's view was that as for Revatio the benefit of Mysildecard outweighs the identified risks.
Estonian: Seetõttu arvas inimravimite komitee, et nagu ka Revatio korral, ületab Mysildecardi kasulikkus sellega kaasnevad riskid.
English: Because the effectiveness and safety of sildenafil in PAH is already well established, studies in people have been limited to tests to determine that it is bioequivalent to another authorised sildenafilcontaining tablet.
Estonian: Et sildenafiili efektiivsus ja ohutus pulmonaalse arteriaalse hüpertensiooni ravis on hästi tõendatud, piirdusid patsiendiuuringud katsetega, milles näidati Mysildecardi bioekvivalentsust teise heakskiidetud sildenafiili sisaldava tabletiga.
English: This means that Mysildecard is similar to a ‘reference medicine' already authorised in the European Union (EU) called Revatio.
Estonian: See tähendab, et Mysildecardi on sarnane võrdlusravimiga Revatio, millel juba on Euroopa Liidus müügiluba.
English: Why is Mysildecard approved?
Estonian: Miks Mysildecard heaks kiideti?
English: For more information about treatment with Mysildecard, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Estonian: Kui vajate Mysildecardiga toimuva ravi kohta lisateavet, lugege palun pakendi infolehte (mis on samuti Euroopa avaliku hindamisaruande osa) või pöörduge oma arsti või apteekri poole.
English: For practical information about using Mysildecard, patients should read the package leaflet or contact their doctor or pharmacist.
Estonian: Kui vajate Mysildecardi kasutamise praktilisi nõuandeid, lugege pakendi infolehte või pöörduge oma arsti või apteekri poole.
English: Mysildecard is a medicine used to treat adults and children from 1 year of age with pulmonary arterial hypertension (PAH, abnormally high blood pressure in the arteries of the lungs).
Estonian: Mysildecardi kasutatakse pulmonaalse arteriaalse hüpertensiooniga (kopsuarterite ebanormaalselt kõrge vererõhk) täiskasvanute ja vähemalt 1aastaste laste raviks.
English: In adults, Mysildecard is taken at a dose of 20 mg three times a day.
Estonian: Täiskasvanud võtavad kolm korda ööpäevas ühe Mysildecardi tableti (20 mg).
English: In adults, it is used in patients with class II (slight limitation of physical activity) or class III (marked limitation of physical activity) PAH.
Estonian: Täiskasvanutel kasutatakse Mysildecardi pulmonaalse arteriaalse hüpertensiooni II klassi (koormustaluvus on veidi piiratud) või III klassi (koormustaluvus on märkimisväärselt piiratud) korral.
English: In children aged one to 17, the recommended dose is 20 mg three times a day in those over 20 kg. Higher doses should not be used.
Estonian: 1-17aastaste üle 20 kg kehamassiga laste soovitatav annus on üks tablett (20 mg) kolm korda ööpäevas.
English: Lower doses of Mysildecard may be needed in patients taking some medicines that affect the way Mysildecard is broken down in the body.
Estonian: Kui patsient võtab teatud ravimeid, mis mõjutavad Mysildecardi lagunemist organismis, võib olla vaja kasutada ravimi väiksemaid annuseid.
English: How does Mysildecard work?
Estonian: Kuidas Mysildecard toimib?
English: What are the benefits and risks of Mysildecard?
Estonian: Milles seisneb Mysildecardi kasulikkus ja mis riskid ravimiga kaasnevad?
English: How is Mysildecard used?
Estonian: Kuidas Mysildecardi kasutatakse?
English: Mysildecard contains the active substance sildenafil.
Estonian: Ravim sisaldab toimeainena sildenafiili.
English: How has Mysildecard been studied?
Estonian: Kuidas Mysildecardi uuriti?
English: Mysildecard can only be obtained with a prescription and treatment should be started and monitored by a doctor who has experience in the treatment of PAH.
Estonian: Ravi tohib määrata ja patsienti peab jälgima pulmonaalse arteriaalse hüpertensiooni ravis kogenud arst.
English: It is a ‘generic medicine'.
Estonian: Mysildecard on geneeriline ravim.
English: Strength Pharmaceutical Form
Estonian: TugevusRavimvorm ManustamisviisPakend
English: Package Leaflet: Information for the User
Estonian: Pakendi infoleht: teave kasutajale
English: Enbrel should only be used during pregnancy if clearly needed.
Estonian: Enbreli võib raseduse ajal kasutada ainult selge vajaduse korral.
English: Do not warm Enbrel in any other way (for example, do not warm it in a microwave or in hot water).
Estonian: Ärge soojendage Enbreli mingil muul moel (näiteks kuumas vees või mikrolaineahjus).
English: Enbrel can be taken with or without food or drink.
Estonian: Enbreli võib kasutada kas koos toidu ja joogiga või ilma.
English: Enbrel is recommended for use in patients as defined in section 4.1.
Estonian: Enbreli on soovitatav kasutada patsientidel nii, nagu kirjeldatud lõigus 4.1.
English: If you received Enbrel during pregnancy, your baby may have a higher risk of getting an infection.
Estonian: Kui saite raseduse ajal Enbreli, võib teie imikul olla kõrgem risk nakkuse saamiseks.
English: • Vaccinations: If possible, children should be up to date with all vaccinations before using Enbrel.
Estonian: • Vaktsineerimine: võimalusel peaksid lapsed saama kõik vajalikud vaktsiinid enne Enbreli kasutamist.
English: Other medicines and Enbrel
Estonian: Muud ravimid ja Enbrel
English: Enbrel is a medicine that is made from two human proteins.
Estonian: Enbrel on ravim, mis on valmistatud kahest inimvalgust.
English: What Enbrel contains
Estonian: Mida Enbrel sisaldab
English: Introduction b.
Estonian: Sissejuhatus b.
English: What Enbrel is and what it is used for
Estonian: Mis ravim on Enbrel ja milleks seda kasutatakse
English: Date of first authorisation: 03 February 2000 Date of last renewal: 03 February 2010
Estonian: Müügiloa esmase väljastamise kuupäev: 3. veebruar 2000 Müügiloa viimase uuendamise kuupäev: 3. veebruar 2010
English: It is important that you tell the baby's doctors and other healthcare professionals about the use of Enbrel during pregnancy before the baby receives any vaccine (for more information see section 2, “Vaccinations”).
Estonian: On oluline, et teavitaksite imiku arsti ja teisi tervishoiu spetsialiste Enbreli kasutamisest raseduse ajal, enne kui imikule manustatakse mis tahes vaktsiini (lisainformatsiooni saamiseks vt lõik 2 „Vaktsineerimised”).
English: It is recommended that you record the date that Enbrel is removed from the refrigerator and the date after which Enbrel should be discarded (no more than 4 weeks following the removal from the refrigerator).
Estonian: Soovitatav on üles märkida kuupäev, millal Enbrel külmikust välja võeti, ja kuupäev, mille järel Enbrel tuleb ära visata (mitte enam kui 4 nädalat pärast külmikust eemaldamist).
English: Do not use Enbrel
Estonian: Ärge kasutage Enbreli
English: • Your doctor will also give you a Patient Alert Card, which contains important safety information that you need to be aware of before and during treatment with Enbrel.
Estonian: • Arst annab teile ka patsiendi hoiatuskaardi, millel on esitatud tähtis ohutusalane teave, mida teil on vaja teada enne ravi Enbreliga ja ravi ajal.
English: • Once the solvent is added to the Enbrel, the plunger may move up by itself.
Estonian: • Kui lahusti on lisatud Enbrelile, võib kolb iseenesest üles liikuda.
English: What Enbrel is and what it is used for What you need to know before you use Enbrel How to use Enbrel
Estonian: Mis ravim on Enbrel ja milleks seda kasutatakse Mida on vaja teada enne Enbreli kasutamist Kuidas Enbreli kasutada
English: In this situation, the benefit/risk balance of Enbrel therapy should be very carefully considered.
Estonian: Sellisel juhul tuleb väga hoolikalt kaaluda Enbreliga ravimise kasu/riski suhet.
English: Responses of Patients with Psoriasis in Studies 2, 3 and 4
Estonian: Psoriaasiga patsientide ravivastus uuringutes 2, 3 ja 4
English: What you need to know before you use Enbrel
Estonian: Mida on vaja teada enne Enbreli kasutamist
English: If you have used more Enbrel than you should (either by injecting too much on a single occasion or by using it too frequently), talk to a doctor or pharmacist immediately.
Estonian: Kui te olete kasutanud rohkem Enbreli kui ette nähtud (kas süstisite ühel korral liiga palju või kasutasite ravimit liiga sageli), rääkige sellest kohe oma arstile või apteekrile.
English: Long-term experience with Enbrel was generally comparable to the original 48-week study and did not reveal any new safety findings.
Estonian: Pikaajaline kogemus Enbreliga oli üldiselt võrreldav algse 48nädalase uuringuga ega näidanud uusi ohutusleide.
English: Your doctor will decide how long you should take Enbrel and whether retreatment is needed based on your response.
Estonian: Arst otsustab, kui kaua peaksite Enbreli kasutama ja kas sõltuvalt ravivastusest on vaja kordusravikuuri.
English: • Alcohol abuse: Enbrel should not be used for the treatment of hepatitis related to alcohol abuse.
Estonian: • Alkoholi kuritarvitamine: Enbreli ei tohi kasutada alkoholi kuritarvitamisega seotud hepatiidi raviks.
English: The effect of Enbrel on radiographic progression was maintained in patients who continued on treatment during the second year.
Estonian: Enbreli mõju radiograafilisele progresseerumisele säilis patsientidel, kes jätkasid ravi teisel aastal.
English: The differences in TSS and JSN were not statistically significant between methotrexate and Enbrel 25 mg.
Estonian: Erinevused TSS ja JSN järgi polnud metotreksaati ja 25 mg Enbreli saanute hulgas statistiliselt olulised.
English: What Enbrel looks like and contents of the pack
Estonian: Kuidas Enbrel välja näeb ja pakendi sisu
English: • Pull the needle completely out of the vial.
Estonian: • Tõmmake nõel viaalist täielikult välja.
English: TSS Erosions
Estonian: TSS Erosiooni
English: If you use more Enbrel than you should
Estonian: Kui te kasutate Enbreli rohkem kui ette nähtud
English: Another study found no increased risk of birth defects when the mother had received Enbrel in pregnancy.
Estonian: Teise uuringu kohaselt ei suurenenud sünnidefektide risk, kui ema oli raseduse ajal saanud Enbreli.
English: In long-term (up to 34 months) open-label studies where Enbrel was given without interruption, clinical responses were sustained and safety was comparable to shorter-term studies.
Estonian: Pikaajalistes (kuni 34 kuud) avatud uuringutes, milles Enbreli kasutati katkestusteta, kliinilised ravivastused püsisid ning ohutus oli võrreldav lühiajaliste uuringutega.
English: In order to improve the traceability of biological medicinal products, the trademark and the batch number of the administered product should be clearly recorded (or stated) in the patient file.
Estonian: Bioloogiliste ravimite kasutamise jälgitavuse parandamiseks tuleb manustatud ravimi kaubanduslik nimetus ja partii number registreerida (esitada) selgelt patsiendi kaardis.
English: Because immunoglobulins, in common with many medicinal products, can be excreted in human milk, a decision must be made whether to discontinue breast-feeding or to discontinue Enbrel therapy, taking into account the benefit of breast-feeding for the child and the benefit of therapy for the woman.
Estonian: Kuna immunoglobuliinid ja paljud ravimid võivad erituda rinnapiima, peab otsustama, kas lõpetada imetamine või Enbrel-ravi imetamise ajaks, kaaludes rinnaga toitmisest saadavat kasu lapsele ja Enbreli ravist saadavat kasu emale.
English: Enbrel works by reducing the inflammation associated with certain diseases.
Estonian: Enbrel vähendab teatud haigustega kaasnevat põletikku.
English: Your doctor will determine the correct dose for the child and will prescribe an appropriate strength of Enbrel (10 mg, 25 mg or 50 mg).
Estonian: Arst otsustab, milline on õige annus lapsele ja määrab sobiva Enbreli tugevuse (10 mg, 25 mg või 50 mg).
English: Some children and teenage patients who have received Enbrel or other medicines that work the same way as Enbrel have developed cancers, including unusual types, which sometimes resulted in death.
Estonian: Mõnel lapsel ja teismeliseeas patsiendil, kes on kasutanud Enbreli või muud Enbreliga sarnase toimega ravimit, on tekkinud vähkkasvajad, sealhulgas ebatavalised vähivormid, mis on mõnikord surmaga lõppenud.
English: If this occurs, you should stop using Enbrel.
Estonian: Kui see juhtub, peate te kohe lõpetama Enbreli kasutamise.
English: If you feel that the effect of Enbrel is too strong or too weak, talk to your doctor or pharmacist.
Estonian: Kui teil on tunne, et Enbreli toime on liiga tugev või liiga nõrk, pidage nõu oma arsti või apteekriga.
English: TNF-antagonists, such as Enbrel, affect the immune system and their use may affect the body's defenses against infection and cancer.
Estonian: TNF-antagonistid nagu Enbrel mõjutavad immuunsüsteemi ning nende kasutamine võib mõjutada organismi kaitsemehhanisme infektsioonide ja vähi vastu.
English: In addition, one study found more birth defects when the mother had received Enbrel in pregnancy, compared with mothers who had not received Enbrel or other similar medicines (TNF-antagonists), but there was no particular kind of birth defect reported.
Estonian: Lisaks, ühe uuringu kohaselt esines sünnidefekte rohkem, kui ema oli saanud raseduse ajal etanertsepti, võrreldes emadega, kes ei olnud etanertsepti ega teisi sarnaseid ravimeid (TNF-antagoniste) saanud, kuid kindlat tüüpi sünnidefekte ei esinenud.
English: Treatment with Enbrel 25 mg resulted in substantial improvement at 12 months, with about 44% of patients achieving a normal HAQ score (less than 0.5).
Estonian: Ravi 25 mg Enbreliga näitas olulist paranemist 12 kuu möödumisel, mil umbes 44% patsientidest oli saavutanud normaalse HAQ punktide arvu (vähem kui 0,5).
English: However, it cannot be excluded that the combination of Enbrel with methotrexate could be associated with an increase in the rate of infections.
Estonian: Siiski ei ole võimalik välistada, et Enbreli ja metotreksaadi kombinatsioonravi kasutamisel võib infektsioonide esinemissagedus suureneda.
English: Such symptoms may point to the existence of potentially life-threatening blood disorders, which may require discontinuation of Enbrel.
Estonian: Need sümptomid võivad viidata potentsiaalselt eluohtlikule verehäirele, mis võib nõuda Enbrel-ravi lõpetamist.
English: After discontinuation of Enbrel, symptoms of arthritis generally returned within a month.
Estonian: Enbreli manustamise katkestamisel ilmnesid artriidi sümptomid üldjuhul 1 kuu jooksul.
English: For patients with multiple symmetrical painful or swollen joints (e.g., hands, wrists and feet), Enbrel can slow down the structural damage to those joints caused by the disease.
Estonian: Mitme sümmeetrilise valuliku või paistes liigese korral (nt käelabad, randmed ja jalalabad) võib Enbrel aeglustada nendes liigestes haiguse tulemusena tekkivaid struktuurseid kahjustusi.
English: Prior to launch in each Member State, the MAH shall agree the final educational material with the competent authority in that Member State comprising of information provided to all healthcare professionals expected to prescribe the product on the correct and safe use of the pre-filled pen and a Patient Alert Card which is to be given to patients using Enbrel.
Estonian: Müügiloa hoidja peab enne Enbreli turule toomist igas liikmesriigis kooskõlastama selle liikmesriigi pädeva ametiga lõpliku õppematerjali, mis koosneb kõikidele ravimit eeldatavalt väljakirjutavatele arstidele mõeldud informatsioonist pen-süstli õige ja ohutu kasutamise kohta ning patsiendi ohutuskaardist, mis tuleb anda Enbreli kasutavatele patsientidele.
English: If the window is not completely purple, contact your nurse or pharmacist for assistance, since the pen may not have injected the Enbrel solution completely.
Estonian: Kui aken ei ole üleni lilla, küsige abi meditsiiniõelt või apteekrilt, sest pen-süstel võis süstida Enbreli lahust puudulikult.
English: If you forget to inject Enbrel
Estonian: Kui te unustate Enbreli süstida
English: Enbrel + Methotrexate
Estonian: Enbrel + metotreksaat
English: Methotrexate Enbrel
Estonian: metotreksaat Enbrel
English: Enbrel can be given as monotherapy in case of intolerance to methotrexate or when continued treatment with methotrexate is inappropriate.
Estonian: Enbreli võib kasutada monoteraapiana metotreksaadi talumatuse puhul või kui jätkuv ravi metotreksaadiga ei ole sobiv.
English: • Leave the syringe in place.
Estonian: • Jätke süstal paigale.
English: Autoantibody formation Treatment with Enbrel may result in the formation of autoimmune antibodies (see section 4.8).
Estonian: Antikehade teke Enbrel-ravi võib põhjustada autoimmuunsete antikehade teket (vt lõik 4.8).
English: The long-term safety of Enbrel in combination with other disease-modifying antirheumatic drugs (DMARD) has not been established.
Estonian: Enbreli pikaajalist ohutust kombinatsioonis teiste haigust modifitseerivate reumavastaste ravimitega (HMR) ei ole kindlaks tehtud.